HIGHLIGHTS
- who: Multiple Sclerosis and colleagues from the Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France, School of Medicine have published the paper: Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis, in the Journal: (JOURNAL)
- what: For a long time, the study of epilepsy has been characterized by a neuro-centric view focused on the imbalance between excitatory and inhibitory transmissions that leads to neuronal hyperexcitability (Naylor, 2010; Bonansco and Fuenzalida, 2016). Considering the possibility to identify novel purine-based astrocyte-targeting treatments for epilepsy and MS, the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.